Pulmonary Fibrosis Biomarker Market to Reach USD 6,538.4 Million by 2034, Growing at a CAGR of 4.4%

The global market for pulmonary fibrosis biomarkers market is on a steady growth trajectory, with sales anticipated to accelerate at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2034. Valued at USD 4,149.0 million in 2023, the market is projected to rise to USD 4,353.0 million by 2024 and further expand to an impressive USD 6,538.4 million by 2034. Pulmonary fibrosis, a …

Pulmonary Fibrosis Biomarker Market Set for Robust Growth, Expected to Reach USD 6,538.4 Million by 2034 at a 4.4% of CAGR

The global market for pulmonary fibrosis biomarkers market is on a steady growth trajectory, with sales anticipated to accelerate at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2034. Valued at USD 4,149.0 million in 2023, the market is projected to rise to USD 4,353.0 million by 2024 and further expand to …